Foghorn Therapeutics Inc Share Price

NASDAQ: FHTX

Small Cap

$4.89

-0.10

(-2.00%)

as on September 17, 2025 at 1:29 am IST

$₹

Foghorn Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$4.88
Day's Price Range
$5.02
$4.89
0.20%
Downside
2.66%
Upside
52 Week's Low
52 Week's High
$2.94
52-Week Price Range
$10.25
$4.89
39.78%
Downside
109.61%
Upside

Foghorn Therapeutics Inc share price movements today

Previous Close: $4.99
Open: $4.92
Volume: 171.5K
Day's Low - High: $4.88 - $5.02
52 Week Low - High: $2.94 - $10.25

Foghorn Therapeutics Inc Historical Returns

1 Month Return: + 0.2 %
3 Month Return: + 4.18 %
1 Year Return: -49.29 %
3 Year Return: -41.98 %
5 Year Return: 0 %

Foghorn Therapeutics Inc Stock Fundamentals & Key Indicators

Check Foghorn Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$282.1M

EPS (TTM)

-1.146

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.05

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-88.7M

Revenue (TTM)

24.2M

Profit Margin

0.00%

Return On Equity TTM

58454500.00%

Foghorn Therapeutics Inc Stock Valuation

Track how Foghorn Therapeutics Inc P/E has moved over time to understand its valuation trends.

Foghorn Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Today (-5.05x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Highest (0.00x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: -5.05x

Foghorn Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Foghorn Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Foghorn Therapeutics Inc	BUY	$282.1M	NA	-5.05	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Foghorn Therapeutics Inc Stock including INR - Dollar returns

The Foghorn Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Foghorn Therapeutics Inc investment value today

Current value as on today

₹54,563

Returns

₹45,437

(-45.44%)

Returns from Foghorn Therapeutics Inc Stock

₹50,305 (-50.3%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Foghorn Therapeutics Inc Stock

Based on 11 analysts

BUY

81.82%

Buy

18.18%

Hold

0.00%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Foghorn Therapeutics Inc. Average target price of $11.67

Foghorn Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Foghorn Therapeutics Inc.

What analysts predicted

58.1%UPSIDE

Target Price

$11.67

Current Price

$4.89

Analyzed by

11 Analysts

Target

$11.67

Foghorn Therapeutics Inc target price $11.67, a slight upside of 58.1% compared to current price of $4.89. According to 11 analysts rating.

Foghorn Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Foghorn Therapeutics Inc Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:17% versus previous 30 day period

Foghorn Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	5	5	17	5	5	6	7	2	5	7
Gross Profit	5	3	16	4	5	6	7	2	5	6
Operating Income	-33	-32	-17	-25	-28	-26	-23	-24	-22	-21
EBITDA	-32	-31	-16	-24	-27	-23	-23	-23	-22	-17
Interest Expense	2	-	-	2	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-29	-28	-13	-22	-25	-22	-19	-19	-18	-17
Income Tax Expense	0	0	0	1	0	-	0	0	-	-
Net Income	-30	-29	-14	-24	-25	-22	-19	-19	-18	-17
Net Profit Margin	-574.27%	-526.65%	-82.07%	-417.85%	-495.37%	-333.61%	-244.90%	-682.88%	-316.43%	-237.34%

Foghorn Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	0	1	19	34	22
Gross Profit	0	-1	-57	-6	19	-75	22
Operating Income	-26	-51	-68	-100	-117	-107	-102
EBITDA	-25	-48	-66	-96	-113	-104	-97
Interest Expense	0	0	0	1	11	-	-
Depreciation	0	0	1	3	3	3	3
Income Before Tax	-26	-51	-68	-101	-108	-94	-86
Income Tax Expense	0	0	0	1	0	4	-
Net Income	-26	-51	-69	-103	-108	-98	-86
Net Profit Margin	0.00%	0.00%	-16227.67%	-7826.08%	-566.23%	-288.17%	-383.24%

Foghorn Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-29	-14	-24	-25	-22	-19	-19	-18	-17
Operating Cash Flow	-32	-27	-27	-29	-25	-21	-24	-23	-21
Investing Cash Flow	39	38	37	27	-17	-61	22	29	33
Financing Cash Flow	0	1	0	1	103	1	0	0	0
Change in Cash	7	12	10	-1	59	-81	-2	5	12

Foghorn Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-51	-68	-101	-108	-98	-86
Operating Cash Flow	-46	-31	-50	193	-118	-100
Investing Cash Flow	0	-108	36	-244	144	-29
Financing Cash Flow	23	217	22	1	1	105
Change in Cash	-23	77	8	-48	28	-24

Global Institutional Holdings in Foghorn Therapeutics Inc

Funds	Holdings
Flagship Ventures Management, Inc.	22.42%
FMR Inc	9.89%
Bvf Inc	9.38%
Deerfield Management Co	5.76%
BlackRock Inc	3.53%

See all

Insights on Foghorn Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 2.85M → 7.55M (in $), with an average increase of 36.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -19.50M → -17.93M (in $), with an average increase of 4.3% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 117.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 153.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, FHTX stock has moved down by -3.1%

About Foghorn Therapeutics Inc

foghorn therapeutics inc., a biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. the company uses its proprietary gene traffic control platform to identify, validate, and potentially drug targets within the system. it is developing fhd-286, a small-molecule enzymatic inhibitor of brg1 and brm for the treatment of acute myeloid leukemia and uveal melanoma; and fhd-609, a small molecule protein degrader of brd9 to treat patients with synovial sarcoma. the company is also developing preclinical and discovery programs, including selective brm targeting non-small-cell lung cancer; and selective arid1b modulators for bladder, ovarian, and endometrial cancer. it has a collaboration with merck sharp & dohme corp. to discover and develop novel oncology therapeutics against a transcription factor target. the company was founded in 2015 and is headquartered in cambridge, massachusetts.

Organisation	Foghorn Therapeutics Inc
Headquarters	500 Technology Square, Cambridge, MA, United States, 02139
Industry	Health Technology
CEO	Mr. Adrian H. B. Gottschalk
E-voting on shares	Click here to vote

Key Management of Foghorn Therapeutics Inc

Name	Title
Mr. Kristian Humer M.B.A.	Chief Financial Officer
Mr. Michael J. LaCascia J.D.	Chief Legal Officer
Mr. Saurabh Sewak Ph.D.	Vice President of Corporate Development
Dr. Steven F. Bellon Ph.D.	Chief Scientific Officer
Ms. Karin Hellsvik	Chief of Staff to the CEO, VP of Corporate Affairs & Investor Relations
Mr. Carlos Costa	Chief People Officer
Dr. Alfonso Quintas Cardama M.D.	Chief Medical Officer
Mr. Adrian H. B. Gottschalk	President, CEO & Director
Dr. Anna Rivkin Ph.D.	Chief Business Officer
Dr. Gerald R. Crabtree M.d.	Founder & Member of Scientific Advisory Board

FAQs

What is Foghorn Therapeutics Inc share price today?

Foghorn Therapeutics Inc share price today is $4.89 as on September 17, 2025 at 1:29 am IST at the close of the market. Foghorn Therapeutics Inc share today touched a day high of $5.02 and a low of $4.88.

What is the 52 week high and 52 week low for Foghorn Therapeutics Inc share?

Foghorn Therapeutics Inc share touched a 52 week high of $10.25 on September 20, 2024 and a 52 week low of $2.94 on April 3, 2025. Foghorn Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $4.89,which is 52.29% down from its 52 week high and 66.06% up from its 52 week low.

What is Foghorn Therapeutics Inc's market capitalisation today?

Foghorn Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Foghorn Therapeutics Inc Stock (FHTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Foghorn Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Foghorn Therapeutics Inc Shares that will get you 0.3067 shares as per Foghorn Therapeutics Inc share price of $4.89 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Foghorn Therapeutics Inc Stock (FHTX) from India?

Indian investors can start investing in Foghorn Therapeutics Inc (FHTX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 1:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Foghorn Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 1:41 pm IST). Based on Foghorn Therapeutics Inc share’s latest price of $4.89 as on September 17, 2025 at 1:29 am IST, you will get 2.0450 shares of Foghorn Therapeutics Inc. Learn more about fractional shares .